Restart of MRI Guided Procedures at Amsterdam UMC

Imricor Medical Systems, Inc. (ASX: $IMR) has announced the restart of routine atrial flutter procedures at the Amsterdam University Medical Centre (Amsterdam UMC) using Imricor's NorthStar 3D mapping system. The team at Amsterdam UMC, led by Dr. Marco Götte, MD PhD, and Professor Cornelis Allaart, MD PhD, successfully performed two procedures today, marking the official reactivation of Amsterdam UMC following the pandemic.

Executive Commentary on MRI Guided Procedures

Dr. Götte expressed satisfaction with the new NorthStar system, highlighting its efficiency in performing complex ablations. He emphasized the value of MRI in these procedures and the excitement about the future advancements. Prof. Allaart also praised the enhanced user experience with NorthStar, enabling faster progress even in challenging cases. Imricor's Chair and CEO, Steve Wedan, expressed enthusiasm for the reactivation of Amsterdam UMC and the upcoming developments in interventional MRI.

Summary of Imricor's Announcement

Amsterdam UMC has resumed routine atrial flutter procedures using Imricor's NorthStar 3D mapping system, showcasing a deep commitment to the growing field of interventional cardiac magnetic resonance (iCMR). The institution is constructing a dedicated iCMR lab, demonstrating its belief in the value MRI adds to these procedures. Imricor's technology is facilitating advancements in iCMR, and the site is expected to participate in Imricor's clinical trials. The company's focus on activating and reactivating sites in 2024 aligns with the groundbreaking work at Amsterdam UMC, a Centre of Excellence for Imricor. Imricor's innovative MRI-compatible products aim to increase the success rates and reduce the overall costs of cardiac ablation procedures, with plans for expanded indications and regulatory approvals in various regions.